A recent study points out that the palmitoylation of CD36 plays a key role in the pathogenesis of NASH by alternating the distribution of CD36 on cell membranes, rather than its expression, which provided a novel functional mode of CD36 (Zhao et al., 2018a). The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.